Tadamitsu Kishimoto

Osaka University


Biomedical Sciences

Kishimoto is one of three awardees of the 2020 Tang Prize in Biopharmaceutical Science for his discovery and cloning of the protein known as interleukin-6 (IL-6), which regulates antibody production. After identifying IL-6, Kishimoto and his team cloned its receptor to demonstrate its role in inflammatory diseases like arthritis—revolutionizing the treatment of rheumatoid and juvenile arthritis.

(Photo: Japan Prize Foundation)

  • Tang Prize in Biopharmaceutical Science

Related articles

Five Scientists From Asia Named 2021 Citation Laureates

Clarivate’s 2021 selection of Citation Laureates honored five scientists from Asia for their transformative work in physiology and chemistry.

Tadamitsu Kishimoto Wins 2020 Tang Prize

Tadamitsu Kishimoto of Osaka University is one of three recipients of the 2020 Tang Prize in Biopharmaceutical Sciences.

Recognizing Scientific Excellence With The Asian Scientist 100

These early career scientists and veteran researchers of the Asian Scientist 100 are making waves in diverse sectors of academia and industry, shedding light on natural phenomena and developing new technologies for a better world.

Tadamitsu Kishimoto Receives 2017 King Faisal International Prize

Professor Tadamitsu Kishimoto has been awarded the King Faisal International Prize for Medicine for his role in developing therapies for autoimmune diseases.